BBLAB
LIVE

Serial Number

79430856

Owner

NUTRIONE CO., LTD.

Filing Date

Jun 23, 2025

Add to watchlist:

No watchlists yet
View on USPTO

BBLAB Trademark

Serial Number: 79430856

BBLAB is a trademark filed by NUTRIONE CO., LTD. on June 23, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

NUTRIONE CO., LTD. (8 trademarks)

42 OLYMPIC-RO 35DA-GIL, SONGPA-GU
SEOUL 05510 , KR

Entity Type: 03

Trademark Details

Filing Date

June 23, 2025

Registration Date

Not Registered

Goods & Services

Mineral/vitamin/lactic acid bacteria supplements; mineral preparations; vitamin and mineral supplements; vitamin tablets; vitamin preparations; chewable tablets for medicines; medicated confectionery; dietary supplements consisting primarily of lactic acid bacteria; nutraceuticals consisting primarily of lactic acid bacteria for use as a dietary supplement; mixed plant extracts tablets for medical purposes; lactic acid bacteria tablets for medical purposes; oriental medicine extracts for medical purposes; multivitamin preparations; nutraceuticals consisting primarily of probiotics for use as a dietary supplement; oriental medicine extracts pharmaceutical preparations; dietary supplement drinks; dietary supplements; anti-oxidants for use as dietary supplements; nutraceuticals consisting primarily of collagen extracted from fish for use as a dietary supplement; nutraceuticals consisting primarily of collagen extracted from fish and shellfish for use as a dietary supplement; nutraceuticals consisting primarily of collagen extracted from milk for use as a dietary supplement; nutraceuticals consisting primarily of collagen extracted from meat for use as a dietary supplement; nutraceuticals consisting primarily of collagen extracted from algae for use as a dietary supplement; meal replacement shakes for medical purposes; dietetic beverages adapted for medical purposes; diet foods for medical purposes; meal replacement and dietary supplement drink mixes for medical purposes; meal replacement snacks for medical purposes; dietetic foods adapted for medical purposes; medical teas for slimming purposes; collagen for medical purposes; medicines for human purposes; medical preparations for slimming purposes; slimming capsules; slimming pills; dietary supplements consisting primarily of collagen; nutritional supplements consisting primarily of collagen; nutraceuticals mainly based on oriental medicine for use as a dietary supplement; food supplement consisting primarily of collagen extracted from milk; food supplement consisting primarily of collagen extracted from meat; dietary supplement mainly based on peony; dietary supplement mainly based on dried orange peel; dietary supplement mainly based on cnidium; food supplement consisting primarily of collagen extracted from seaweed; dietary supplement mainly based on safflower leaf; food supplement consisting primarily of vitamin extracted from fruits; food supplement consisting primarily of lactic acid bacteria; food supplement consisting primarily of probiotics lactic acid bacteria extracted from milk products; food supplement mainly based on minerals extracted from vegetable; dietary supplement mainly based on cinnamon; dietary supplement mainly based on angelica root; dietary supplement mainly based on bamboo leaf; dietary supplement mainly based on white atractylis; food supplement consisting primarily of collagen extracted from fish; food supplement consisting primarily of collagen extracted from fish and shellfish; dietary supplement mainly based on corn silk

Filing History

REFUSAL PROCESSED BY IB
Jan 8, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 22, 2025 RFCS
REFUSAL PROCESSED BY MPU
Dec 22, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 18, 2025 RFCR
NON-FINAL ACTION WRITTEN
Nov 17, 2025 CNRT
ASSIGNED TO EXAMINER
Nov 10, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 19, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 19, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 18, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 21, 2025 REPR